Equillium (EQ) Enterprise Value (2017 - 2026)
Equillium (EQ) posted quarterly Enterprise Value of -$61.3 million for Q1 2026, down 322.91% year-over-year from $27.5 million in Q1 2025, and down 106.24% quarter-over-quarter from -$29.7 million in Q4 2025.
Equillium (EQ) Enterprise Value (2017 - 2026) Analysis & Trends
Equillium (EQ) has reported Enterprise Value for 10 consecutive years, with -$61.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Enterprise Value fell 322.91% year-over-year to -$61.3 million; the TTM figure through Mar 2026 stood at -$61.3 million (down 322.91% YoY), while the FY2025 annual figure was -$29.7 million, down 31.71% from the prior year.
- Enterprise Value retreated to -$61.3 million in Q1 2026 per EQ's latest filing, from -$29.7 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$10.3 million in Q2 2025 and bottomed at -$71.0 million in Q4 2022.
- Historically, Enterprise Value has averaged -$41.3 million across 5 years, with a median of -$40.9 million in 2023.
- Annual changes were most pronounced in 2025 — Enterprise Value surged 69.17% — and 2026, when it tumbled 322.91%.
- Equillium's Enterprise Value stood at -$71.0 million in 2022, then soared by 42.46% to -$40.9 million in 2023, then surged by 44.76% to -$22.6 million in 2024, then plunged by 31.71% to -$29.7 million in 2025, then sank by 106.24% to -$61.3 million in 2026.
- Business Quant data shows EQ's Enterprise Value at -$61.3 million in Q1 2026, -$29.7 million in Q4 2025, and -$33.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Equillium | 263.86 Mn | 263.86 Mn | - | -57.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -57.20 Mn |
| Mar 31, 2026 | -61.32 Mn |
| Dec 31, 2025 | -29.73 Mn |
| Sep 30, 2025 | -33.10 Mn |
| Jun 30, 2025 | -10.27 Mn |
| Mar 31, 2025 | -14.50 Mn |
| Dec 31, 2024 | -22.58 Mn |
| Sep 30, 2024 | -25.88 Mn |
| Jun 30, 2024 | -33.30 Mn |
| Mar 31, 2024 | -32.29 Mn |
| Dec 31, 2023 | -40.87 Mn |
| Sep 30, 2023 | -46.31 Mn |
| Jun 30, 2023 | -48.38 Mn |
| Mar 31, 2023 | -61.99 Mn |
| Dec 31, 2022 | -71.02 Mn |
| Sep 30, 2022 | -44.52 Mn |
| Jun 30, 2022 | -57.56 Mn |
| Mar 31, 2022 | -68.82 Mn |
| Dec 31, 2021 | -80.71 Mn |
| Sep 30, 2021 | -90.69 Mn |